Reducing the burden of diabetes treatment: A review of low-cost oral hypoglycemic medications.

CONCLUSIONS: Metformin, glimepiride, and pioglitazone are safe and efficacious OHMs. Prescribing at the EFF rather than the MAX may avoid negative dose-related outcomes. OHMs should be evaluated as individual drugs, not generalized as a class, due to different dosing and adverse-event profiles; Glimepiride is the preferred sulfonylurea since it is not associated with the adverse events of others in its class.
PMID: 32026779 [PubMed - as supplied by publisher]

Source: Current Diabetes Reviews - February 4, 2020 Category: Endocrinology Authors: Vaughan EM, Rueda JJ, Samson SL, Hyman DJ Tags: Curr Diabetes Rev Source Type: research